Product
Rabeprazloe+bismuth+amoxicillin+clarithromycin
1 clinical trial
1 indication
Indication
Eradication Rates of Helicobacter PyloriClinical trial
Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication: A Single-center, Randomised, Controlled Trial.Status: Recruiting, Estimated PCD: 2024-06-25